Premenstrual Dysphoric Disorder in an Adolescent Female

Journal of Pediatric and Adolescent Gynecology

Volumn 20, Issue 3, 2007, Pages 201-204

  Nur, Marcela M ^a   Romano, Mary E ^a   Siqueira, Lorena M ^a  

^a MIAMI CHILDREN'S HOSPITAL   (United States)

Author keywords

Fluoxetine; Premenstrual dysphoric disorder; Premenstrual syndrome; Selective serotonin reuptake inhibitors

Indexed keywords

ETHINYLESTRADIOL PLUS LEVONORGESTREL; FLUOXETINE;

ADOLESCENT; ADOLESCENT HEALTH; ANAMNESIS; ARTICLE; BEHAVIOR CHANGE; CASE REPORT; CLINICAL FEATURE; DYSMENORRHEA; FEMALE; FOLLOW UP; HORMONAL THERAPY; HUMAN; HYDROCEPHALUS; LUTEAL PHASE; MENSTRUAL CYCLE; PHYSICAL EXAMINATION; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; SHUNTING; TREATMENT OUTCOME;

ADOLESCENT; DEPRESSIVE DISORDER; FEMALE; FLUOXETINE; HUMANS; LUTEAL PHASE; PREMENSTRUAL SYNDROME; SEROTONIN UPTAKE INHIBITORS;

EID: 34249876891     PISSN: 10833188     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpag.2006.09.014     Document Type: Article

References (27)

1. Mishell Jr. D.R. Premenstrual disorders: epidemiology and disease burden. Am J Manag Care 11 16 Suppl (2005) S473
2. Premenstrual dysphoric disorder. Diagnostic and Statistical Manual of Mental Disorders. 4th, Text Revision ed (2000), American Psychiatric Association, Washington, DC 771
3. Freeman E.W. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology 28 Suppl 3 (2003) 25
4. Ross L.E., and Steiner M. A biopsychosocial approach to premenstrual dysphoric disorder. Psychiatr Clin North Am 26 (2003) 529
5. Halbreich U., Borenstein J., Pearlstein T., et al. The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneurondocrinology 28 Suppl 3 (2003) 1
6. Tabassum S., Afridi B., Aman Z., et al. Premenstrual syndrome: frequency and severity in young college girls. J Pak Med Assoc 55 (2005) 546
7. Warnock J.K., and Clayton A.H. Chronic episodic disorders in women. Psychiatr Clin North Am 26 (2003) 725
8. Backstrom T., Andersson A., Andree L., et al. Pathogenesis in menstrual cycle-linked CNS disorders. Ann N Y Acad Sci 1007 (2003) 42
9. Girdler S.S., Straneva P.A., Light K.C., et al. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder. Biol Psychiatry 49 (2001) 788
10. Rapkin A.J., Edelmuth E., Chang L.C., et al. Whole-blood serotonin in premenstrual syndrome. Obstet Gynecol 70 (1987) 533
11. Wihlback A.C., Sundstrom Poromaa I., et al. Influence of menstrual cycle on platelet serotonin uptake site and serotonin2A receptor binding. Psychoneuroendocrinology 29 (2004) 757
12. Bang L.M., and Keating G.M. Paroxetine controlled release. CNS Drugs 18 (2004) 355
13. Freeman E.W. Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder. CNS Drugs 18 (2004) 453
14. Luisi A.F., and Pawasauskas J.E. Treatment of premenstrual dysphoric disorder with selective serotonin reuptake inhibitors. Pharmacotherapy 23 (2003) 1131
15. Pearlstein T. Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?. Drugs 62 (2002) 1869
16. Steiner M., and Born L. Diagnosis and treatment of premenstrual dysphoric disorder: an update. Int Clin Psychopharmacol 15 Suppl 3 (2000) S5
17. Steiner M., Pearlstein T., Cohen L.S., et al. Expert guidelines for the treatment of severe PMS, PMDD, and comorbidities: the role of SSRIs. J Womens Health (Larchmt) 15 (2006) 57
18. Rapkin A.J., and Mikacich J.A. Premenstrual syndrome in adolescents: diagnosis and treatment. Pediatr Endocrinol Rev 3 Suppl 1 (2006) 132
19. Silber T.J., and Valadez-Meltzer A. Premenstrual dysphoric disorder in adolescents: case reports of treatment with fluoxetine and review of the literature. J Adolesc Health 37 (2005) 518
20. Wittchen H.U., Becker E., Lieb R., et al. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 32 (2002) 119
21. Cohen L.S., Miner C., Brown E.W., et al. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries. Obstet Gynecol 100 (2002) 435
22. Pearlstein T., Joliat M.J., Brown E.B., et al. Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment. Am J Obstet Gynecol 188 (2003) 887
23. Endicott J., Amsterdam J., Eriksson E., et al. Is premenstrual dysphoric disorder a distinct clinical entity?. J Womens Health Gend Based Med 8 (1999) 663
24. Reape K.Z. Current contraceptive research and development. Adolesc Med Clin 16 (2005) 617
25. Freeman E.W., Kroll R., Rapkin A., et al. Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder. J Womens Health Gend Based Med 10 (2001) 561
26. Freeman E.W. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder. Eur J Contracept Reprod Health Care 7 Suppl 3 (2002) 27
27. Kroll R., and Rapkin A.J. Treatment of premenstrual disorders. J Reprod Med 51 4 Suppl (2006) 359